Centaurus Financial’s Varian Medical Systems, Inc. VAR Stock Holding History

Centaurus Financial’s Portfolio VAR Stock Details VAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-60	Closed	-$7K	–	2288
2018 Q2	$7K	Buy	+60	New	+$7.18K	﹤0.01%	1703

Other funds holding VAR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Centaurus Financial's VAR Position: Q3 2018 in Review

Centaurus Financial sold out of Varian Medical Systems, Inc. (VAR) in Q3 2018, closing a stake of 60 shares — an estimated $7K sold.

Centaurus Financial first reported a position in VAR in Q2 2018 and held it in 1 quarter. The position peaked at $7K in Q2 2018. 574 funds tracked by Wall St. Rank hold VAR as of Q3 2018.

Centaurus Financial reported no remaining Varian Medical Systems, Inc. position as of Q3 2018 after selling out during the quarter.
Centaurus Financial sold 60 Varian Medical Systems, Inc. shares in Q3 2018, an estimated $7K.
Centaurus Financial first reported a position in Varian Medical Systems, Inc. in Q2 2018 and held it in 1 quarter.
Centaurus Financial's Varian Medical Systems, Inc. position peaked at $7K in Q2 2018.
574 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.